|
⚲
|
| Keyboard |
| Flagship Ventures Fund 2004 L P
✚
|
|
|---|---|
| CIK # | 0001299790 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001299790] | |
| 4 | [0001299790] | |
| SC 13G | [0001299790] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Flagship Ventures Fund 2004 L P | Quanterix Corp | [2018-02-14] |
| Flagship Ventures Fund 2004 L P | T2 Biosystems Inc | [2015-02-12] |
| Flagship Ventures Fund 2004 L P | Bind Therapeutics Inc | [2014-02-10] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Quanterix Corp QTRX
Series C Preferred Stock · derivative
|
2017-12-11 | Conversion | 352,800 | ||
|
Quanterix Corp QTRX
Common Stock
|
2017-12-11 | Conversion | 109,770 | ||
|
Quanterix Corp QTRX
Common Stock
|
2017-12-11 | Conversion | 477,042 | ||
|
Quanterix Corp QTRX
Common Stock
|
2017-12-11 | Conversion | 1,045,426 | ||
|
Quanterix Corp QTRX
Common Stock
|
2017-12-11 | Conversion | 398,257 | ||
|
Quanterix Corp QTRX
Series A-1 Preferred Stock · derivative
|
2017-12-11 | Conversion | 1,280,000 | ||
|
Quanterix Corp QTRX
Series A-2 Preferred Stock · derivative
|
2017-12-11 | Conversion | 3,360,000 | ||
|
Quanterix Corp QTRX
Series B Preferred Stock · derivative
|
2017-12-11 | Conversion | 1,533,214 | ||
|
T2 Biosystems Inc TTOO
Common Stock
|
2014-08-12 | Conversion | 1,632,816 | $0.00 | |
|
T2 Biosystems Inc TTOO
Common Stock
|
2014-08-12 | Conversion | 741,755 | $0.00 | |
|
T2 Biosystems Inc TTOO
Series A-1 Convertible Preferred Stock · derivative
|
2014-08-12 | Conversion | 128,567 | $0.00 | |
|
T2 Biosystems Inc TTOO
Series B Convertible Preferred Stock · derivative
|
2014-08-12 | Conversion | 1,053,201 | $0.00 | |
|
T2 Biosystems Inc TTOO
Series A-2 Convertible Preferred Stock · derivative
|
2014-08-12 | Conversion | 774,527 | $0.00 | |
|
T2 Biosystems Inc TTOO
Series E Convertible Preferred Stock · derivative
|
2014-08-12 | Conversion | 631,133 | $0.00 | |
|
T2 Biosystems Inc TTOO
Series D Convertible Preferred Stock · derivative
|
2014-08-12 | Conversion | 629,851 | $0.00 | |
|
T2 Biosystems Inc TTOO
Series C Convertible Preferred Stock · derivative
|
2014-08-12 | Conversion | 819,493 | $0.00 | |
|
Concert Pharmaceuticals Inc CNCE
Series B Convertible Preferred Stock · derivative
|
2014-02-19 | Conversion | 3,000,000 | $0.00 | |
|
Concert Pharmaceuticals Inc CNCE
Common Stock
|
2014-02-19 | Conversion | 530,974 | ||
|
Concert Pharmaceuticals Inc CNCE
Common Stock
|
2014-02-19 | Conversion | 93,008 | ||
|
Concert Pharmaceuticals Inc CNCE
Series C Convertible Preferred Stock · derivative
|
2014-02-19 | Conversion | 525,500 | $0.00 | |
| showing 20 of 38 most recent transactions | |||||